MedPath

Web-based Insulin Titration - An Efficacy Study

Not Applicable
Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
Device: Web-based insulin titration
Registration Number
NCT01715090
Lead Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Brief Summary

The main objective of the study is to determine whether an intensive web-based titration system, called PANDIT (Patient Assisting Net-based Diabetes Insulin Titration), is effective in improving glycaemic control in patients with diabetes mellitus type 2 using a basal insulin, compared to standard care.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
73
Inclusion Criteria
  • Male or female between 18 and 80 years
  • Type 2 diabetes mellitus (diagnosed clinically) for ≥ 6 months
  • Once daily basal insulin therapy usage
  • No restriction on HbA1c or FPG
  • BMI < 40 kg/m2
  • Ability to read and understand the Dutch language
  • Familiarity with the Internet and use of a mobile phone
  • Ability and willingness to adhere to the protocol
  • Ability and willingness to use a web-based insulin self-titration system
  • Confirmed written consent
Exclusion Criteria
  • Type 1 diabetes
  • Use of systemic corticosteroid in the last three months
  • Recurrent severe hypoglycaemia or hypoglycaemic unawareness
  • Active proliferative diabetic retinopathy
  • Any clinically significant disease or disorder
  • Mental condition rendering the patient unable to understand the nature, scope and possible consequences of the study
  • Working in night shifts

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Web-based insulin titrationWeb-based insulin titrationAn online web-based insulin titration algorithm to guide patients in self-titration
Primary Outcome Measures
NameTimeMethod
Mean change in HbA1cChange from baseline after 13 weeks and after 26 weeks
Secondary Outcome Measures
NameTimeMethod
Proportion of subjects who reach the target of HbA1c < 7.0%After 26 weeks
Quality of life and treatment satisfactionChange from baseline after 13 weeks and after 26 weeks
Total contact time with study staff (and the PANDIT system, if applicable)After 26 weeks
Overall incidence and rate of hypoglycaemia (mild hypoglycaemia, probable hypoglycaemia, severe hypoglycaemia and relative hypoglycaemia)After 26 weeks
Detection of important factors for patient compliance to internet-based self-care interventionsAfter 26 weeks
Mean change in fasting plasma glucoseChange from baseline after 13 weeks and after 26 weeks
Frequency of the usage of PANDIT among patientsAfter 26 weeks

Trial Locations

Locations (1)

Academic Medical Center

đŸ‡³đŸ‡±

Amsterdam, Netherlands

© Copyright 2025. All Rights Reserved by MedPath